241 related articles for article (PubMed ID: 11376123)
41. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
42. β-Catenin/POU5F1/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma.
Xu C; Xie D; Yu SC; Yang XJ; He LR; Yang J; Ping YF; Wang B; Yang L; Xu SL; Cui W; Wang QL; Fu WJ; Liu Q; Qian C; Cui YH; Rich JN; Kung HF; Zhang X; Bian XW
Cancer Res; 2013 May; 73(10):3181-9. PubMed ID: 23539445
[TBL] [Abstract][Full Text] [Related]
43. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
44. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
Stewart CE; Newcomb PV; Savage PB; Dickens M; Tavare J; Holly JM
Growth Horm IGF Res; 1999 Apr; 9(2):131-42. PubMed ID: 10373346
[TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair.
Héron-Milhavet L; Karas M; Goldsmith CM; Baum BJ; LeRoith D
J Biol Chem; 2001 May; 276(21):18185-92. PubMed ID: 11278917
[TBL] [Abstract][Full Text] [Related]
46. Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction.
Dupont J; LeRoith D
Horm Res; 2001; 55 Suppl 2():22-6. PubMed ID: 11684871
[TBL] [Abstract][Full Text] [Related]
47. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
del Rincón SV; Rousseau C; Samanta R; Miller WH
Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186
[TBL] [Abstract][Full Text] [Related]
48. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim EJ; Kang IJ; Cho HJ; Kim WK; Ha YL; Park JH
J Nutr; 2003 Aug; 133(8):2675-81. PubMed ID: 12888657
[TBL] [Abstract][Full Text] [Related]
49. Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1.
Navarro M; Valentinis B; Belletti B; Romano G; Reiss K; Baserga R
Endocrinology; 2001 Dec; 142(12):5149-57. PubMed ID: 11713209
[TBL] [Abstract][Full Text] [Related]
50. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
[TBL] [Abstract][Full Text] [Related]
51. Differential regulation of signaling pathways for insulin and insulin-like growth factor I.
Lopaczynski W
Acta Biochim Pol; 1999; 46(1):51-60. PubMed ID: 10453981
[TBL] [Abstract][Full Text] [Related]
52. Genetic engineering in mice: impact on insulin signalling and action.
Lamothe B; Baudry A; Desbois P; Lamotte L; Bucchini D; De Meyts P; Joshi RL
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):193-204. PubMed ID: 9761714
[TBL] [Abstract][Full Text] [Related]
53. The role of insulin receptor substrate-1 in transformation by v-src.
Sun H; Baserga R
J Cell Physiol; 2008 Jun; 215(3):725-32. PubMed ID: 18064649
[TBL] [Abstract][Full Text] [Related]
54. Anti-apoptotic signaling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-Raf and Nedd4.
Peruzzi F; Prisco M; Morrione A; Valentinis B; Baserga R
J Biol Chem; 2001 Jul; 276(28):25990-6. PubMed ID: 11352919
[TBL] [Abstract][Full Text] [Related]
55. The contradictions of the insulin-like growth factor 1 receptor.
Baserga R
Oncogene; 2000 Nov; 19(49):5574-81. PubMed ID: 11114737
[TBL] [Abstract][Full Text] [Related]
56. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.
Buck E; Eyzaguirre A; Rosenfeld-Franklin M; Thomson S; Mulvihill M; Barr S; Brown E; O'Connor M; Yao Y; Pachter J; Miglarese M; Epstein D; Iwata KK; Haley JD; Gibson NW; Ji QS
Cancer Res; 2008 Oct; 68(20):8322-32. PubMed ID: 18922904
[TBL] [Abstract][Full Text] [Related]
57. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit.
Fischer-Posovszky P; Tornqvist H; Debatin KM; Wabitsch M
Endocrinology; 2004 Apr; 145(4):1849-59. PubMed ID: 14691011
[TBL] [Abstract][Full Text] [Related]
59. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways.
Valentinis B; Romano G; Peruzzi F; Morrione A; Prisco M; Soddu S; Cristofanelli B; Sacchi A; Baserga R
J Biol Chem; 1999 Apr; 274(18):12423-30. PubMed ID: 10212216
[TBL] [Abstract][Full Text] [Related]
60. Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation.
Stachelscheid H; Ibrahim H; Koch L; Schmitz A; Tscharntke M; Wunderlich FT; Scott J; Michels C; Wickenhauser C; Haase I; Brüning JC; Niessen CM
EMBO J; 2008 Aug; 27(15):2091-101. PubMed ID: 18650937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
